CU

Chowalloorwariam Unnikrishnan Achuthawarrier

Director Additional Director DIN 07857912
DIN 07857912 First appointment Jun 2017 Primary industry Life Sciences
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Jun 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Chowalloorwariam Unnikrishnan Achuthawarrier

Data last updated:

Chowalloorwariam Unnikrishnan Achuthawarrier was an Additional Director at Karmmafarms And Biotech Private Limited (2017–2018). The company operates in Life Sciences.

DIN 07857912
Primary Designation Additional Director
Industry Life Sciences
First Appointment 22 Jun 2017

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director22 Jun 20172017Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Karmmafarms And Biotech Private Limited
Premium access

Shareholding and investment profile for Chowalloorwariam Unnikrishnan Achuthawarrier

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chowalloorwariam Unnikrishnan Achuthawarrier

Chowalloorwariam Unnikrishnan Achuthawarrier was first appointed on 22 Jun 2017 as Additional Director at Karmmafarms And Biotech Private Limited.

Chowalloorwariam Unnikrishnan Achuthawarrier held 1 earlier board appointment: Karmmafarms And Biotech Private Limited (Additional Director, 22 Jun 2017 to 21 May 2018).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available